
Sabiha Naim Qazi
Examiner (ID: 9471, Phone: (571)272-0622 , Office: P/1621 )
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1629, 1611, 1621, 1612, 1202, 1616, 1628, 1627 |
| Total Applications | 2032 |
| Issued Applications | 930 |
| Pending Applications | 195 |
| Abandoned Applications | 909 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8780598
[patent_doc_number] => 20130102573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => '2-METHYLENE-VITAMIN D ANALOGS AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 13/647641
[patent_app_country] => US
[patent_app_date] => 2012-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15121
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13647641
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/647641 | 2-methylene-vitamin D analogs and their uses | Oct 8, 2012 | Issued |
Array
(
[id] => 8780592
[patent_doc_number] => 20130102567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => '3-Desoxy-2-Methylene-Vitamin D Analogs and Their Uses'
[patent_app_type] => utility
[patent_app_number] => 13/633975
[patent_app_country] => US
[patent_app_date] => 2012-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12981
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13633975
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/633975 | 3-desoxy-2-methylene-vitamin D analogs and their uses | Oct 2, 2012 | Issued |
Array
(
[id] => 8756184
[patent_doc_number] => 20130090486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-11
[patent_title] => 'Crystallization of 1alpha-Hydroxy-2-Methylene-18,19-Dinor-Homopregnacalciferol'
[patent_app_type] => utility
[patent_app_number] => 13/632791
[patent_app_country] => US
[patent_app_date] => 2012-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 36937
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13632791
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/632791 | Crystallization of 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol | Sep 30, 2012 | Issued |
Array
(
[id] => 8612710
[patent_doc_number] => 20130018021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => '2Alpha-Methyl and 2Beta-Methyl Analogs of 19,26,27-Trinor-(20S)-1Alpha-Hydroxyvitamin D3 and Their Uses'
[patent_app_type] => utility
[patent_app_number] => 13/622195
[patent_app_country] => US
[patent_app_date] => 2012-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10403
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13622195
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/622195 | 2α-methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and their uses | Sep 17, 2012 | Issued |
Array
(
[id] => 13137541
[patent_doc_number] => 10086082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Plant steroids and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/345028
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 7762
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14345028
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/345028 | Plant steroids and uses thereof | Sep 13, 2012 | Issued |
Array
(
[id] => 8707614
[patent_doc_number] => 20130064903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'RHEUMATIOD ARTHRITIS CURE'
[patent_app_type] => utility
[patent_app_number] => 13/604424
[patent_app_country] => US
[patent_app_date] => 2012-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 908
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13604424
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/604424 | RHEUMATIOD ARTHRITIS CURE | Sep 4, 2012 | Abandoned |
Array
(
[id] => 9719618
[patent_doc_number] => 20140255317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'PREPARATION COMPRISING HEXOSE-6-PHOSPHATE-MODIFIED CHOLESTEROL DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 14/343318
[patent_app_country] => US
[patent_app_date] => 2012-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11510
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343318
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/343318 | PREPARATION COMPRISING HEXOSE-6-PHOSPHATE-MODIFIED CHOLESTEROL DERIVATIVE | Sep 4, 2012 | Abandoned |
Array
(
[id] => 8685072
[patent_doc_number] => 20130053356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => '2-METHYLENE-19,23,24-TRINOR-1ALPHA-HYDROXYVITAMIN D3'
[patent_app_type] => utility
[patent_app_number] => 13/592921
[patent_app_country] => US
[patent_app_date] => 2012-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8069
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13592921
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/592921 | 2-METHYLENE-19,23,24-TRINOR-1ALPHA-HYDROXYVITAMIN D3 | Aug 22, 2012 | Abandoned |
Array
(
[id] => 8995284
[patent_doc_number] => 08519169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'Crystallization a 1alpha-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvitamin D3'
[patent_app_type] => utility
[patent_app_number] => 13/588608
[patent_app_country] => US
[patent_app_date] => 2012-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5904
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13588608
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/588608 | Crystallization a 1alpha-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvitamin D3 | Aug 16, 2012 | Issued |
Array
(
[id] => 8482835
[patent_doc_number] => 20120282242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'COMPOSITIONS, TARGETS, METHODS AND DEVICES FOR THE THERAPY OF OCULAR AND PERIOCULAR DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/554349
[patent_app_country] => US
[patent_app_date] => 2012-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20148
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13554349
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/554349 | COMPOSITIONS, TARGETS, METHODS AND DEVICES FOR THE THERAPY OF OCULAR AND PERIOCULAR DISORDERS | Jul 19, 2012 | Abandoned |
Array
(
[id] => 8904795
[patent_doc_number] => 20130172299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'Combination Therapy for Treatment of Bone and Mineral Disorders for Patients with Impaired Renal Function'
[patent_app_type] => utility
[patent_app_number] => 13/553738
[patent_app_country] => US
[patent_app_date] => 2012-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6142
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13553738
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/553738 | Combination Therapy for Treatment of Bone and Mineral Disorders for Patients with Impaired Renal Function | Jul 18, 2012 | Abandoned |
Array
(
[id] => 8483794
[patent_doc_number] => 20120283201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => '9-SUBSTITUTED MINOCYCLINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/547870
[patent_app_country] => US
[patent_app_date] => 2012-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10954
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13547870
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/547870 | 9-substituted minocycline compounds | Jul 11, 2012 | Issued |
Array
(
[id] => 8465890
[patent_doc_number] => 20120271058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'STEREOSELECTIVE SYNTHESIS OF VITAMIN D ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 13/533405
[patent_app_country] => US
[patent_app_date] => 2012-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12581
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13533405
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/533405 | Stereoselective synthesis of vitamin D analogues | Jun 25, 2012 | Issued |
Array
(
[id] => 8430893
[patent_doc_number] => 20120252768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'COMPOSITION CONTAINING PROTOPANAXATRIOL AND PROTOPANAXADIOL'
[patent_app_type] => utility
[patent_app_number] => 13/495031
[patent_app_country] => US
[patent_app_date] => 2012-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6383
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13495031
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/495031 | COMPOSITION CONTAINING PROTOPANAXATRIOL AND PROTOPANAXADIOL | Jun 12, 2012 | Abandoned |
Array
(
[id] => 8371071
[patent_doc_number] => 20120220462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'INDUCING AGENT FOR PLANT ROOT'
[patent_app_type] => utility
[patent_app_number] => 13/467449
[patent_app_country] => US
[patent_app_date] => 2012-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9466
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13467449
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/467449 | INDUCING AGENT FOR PLANT ROOT | May 8, 2012 | Abandoned |
Array
(
[id] => 9108286
[patent_doc_number] => 20130281418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'Use of hydroxypregnenolone derivatives for enhancing health and physical performance'
[patent_app_type] => utility
[patent_app_number] => 13/506518
[patent_app_country] => US
[patent_app_date] => 2012-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4429
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13506518
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/506518 | Use of hydroxypregnenolone derivatives for enhancing health and physical performance | Apr 22, 2012 | Abandoned |
Array
(
[id] => 8465775
[patent_doc_number] => 20120270943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'D-aspartic Acid Pro-nutrients with Improved Solubility Characteristics'
[patent_app_type] => utility
[patent_app_number] => 13/451751
[patent_app_country] => US
[patent_app_date] => 2012-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1864
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13451751
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/451751 | D-aspartic Acid Pro-nutrients with Improved Solubility Characteristics | Apr 19, 2012 | Abandoned |
Array
(
[id] => 8348087
[patent_doc_number] => 20120209016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'Exemestane and its Intermediates and Methods of Making the Same'
[patent_app_type] => utility
[patent_app_number] => 13/451034
[patent_app_country] => US
[patent_app_date] => 2012-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7838
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13451034
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/451034 | Exemestane and its intermediates and methods of making the same | Apr 18, 2012 | Issued |
Array
(
[id] => 8904797
[patent_doc_number] => 20130172300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'NEW HORMONAL COMPOSITION AND ITS USE'
[patent_app_type] => utility
[patent_app_number] => 13/448953
[patent_app_country] => US
[patent_app_date] => 2012-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6069
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448953
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/448953 | Hormonal composition and its use | Apr 16, 2012 | Issued |
Array
(
[id] => 8323649
[patent_doc_number] => 20120196057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'COMBINATION OF VITAMIN D AND 25-HYDROXYVITAMIN D 3'
[patent_app_type] => utility
[patent_app_number] => 13/446128
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8225
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13446128
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/446128 | COMBINATION OF VITAMIN D AND 25-HYDROXYVITAMIN D 3 | Apr 12, 2012 | Abandoned |